ong-term Follow-up of Patients with Spinal Muscular Atrophy Treated with OAV101 in Clinical trials
Phase 3
- Conditions
- Spinal Muscular Atrophy
- Registration Number
- JPRN-jRCT2033230642
- Lead Sponsor
- Hirano Takamitsu
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 4
Inclusion Criteria
1. Participated in an OAV101 clinical trial.
2. Written informed consent must be obtained before any assessment is performed.
3. Patient/Parent/legal guardian willing and able to comply with study procedures.
Exclusion Criteria
There are no exclusion criteria for this study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method